NeuMoDx PrEDiCTiNG Study Evaluation Plan
Public ClinicalTrials.gov record NCT03970850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center Clinical Performance Evaluation of the NeuMoDx™ Chlamydia Trachomatis (CT) / Neisseria Gonorrhoeae (NG) [CT/NG] Assay on the NeuMoDx™ 288 Molecular System and the NeuMoDx™96 Molecular System
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This investigational study will be conducted to evaluate the performance of the NeuMoDx™ CT/NG Assay on the NeuMoDx™ 288 Molecular System and NeuMoDx™ 96 Molecular System (collectively referred to as NeuMoDx™ CT/NG Assay test system).
Study identification
- NCT ID
- NCT03970850
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 4,017 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 14 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2019 (Actual)
- Primary completion
- Feb 25, 2020 (Actual)
- Completion
- Feb 25, 2020 (Actual)
- Last update posted
- Jun 12, 2020
2019 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Healthcare Clinical Date, Inc. (Segal Trials) | North Miami | Florida | 33161 | — |
| Planned Parenthood - Southwest and Central Florida | Orlando | Florida | 32817 | — |
| Planned Parenthood - Southwest and Central Florida | Tampa | Florida | 33617 | — |
| Indiana University (IU) | Indianapolis | Indiana | 46202 | — |
| LSU Health Science | New Orleans | Louisiana | 70112 | — |
| NeuMoDx Molecular, Inc. | Ann Arbor | Michigan | 48108 | — |
| Henry Ford Health System (HFHS) | Detroit | Michigan | 48202 | — |
| Planned Parenthood - Northern, Central and Southern New Jersey | Elizabeth | New Jersey | 07201 | — |
| Planned Parenthood - Northern, Central and Southern New Jersey | Newton | New Jersey | 07860 | — |
| Planned Parenthood - Northern, Central and Southern New Jersey | Riverside Park | New Jersey | 08075 | — |
| TriCore Reference Labs | Albuquerque | New Mexico | 87505 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| Planned Parenthood - Gulf Coast | Houston | Texas | 77023 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03970850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2020 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03970850 live on ClinicalTrials.gov.